Trial Profile
Clinical Trials Insight: 700036930
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 09 Sep 2008
Price :
$35
*
At a glance
- Drugs Etheophazine (Primary)
- Indications Cancer
- Focus Therapeutic Use
- Sponsors Sinobiomed
- 09 Sep 2008 New trial record.